Literature DB >> 2358334

Interstitial brachytherapy and early tongue squamous cell carcinoma management.

J L Lefebvre1, B Coche-Dequeant, B Castelain, B Prevost, E Buisset, J Ton Van.   

Abstract

The results of treatment of 341 previously untreated patients with early squamous cell carcinoma (SCC) of the anterior two thirds of the tongue using iridium 192 implants (January 1974-December 1983) are presented. Furthermore, 265 patients underwent neck dissection, followed, in 102 cases, by radiotherapy. Incidence of local treatment complications was 19% (66 patients; however, only 3% (11 patients) needed more than a single medical treatment. Two months after completion of overall treatment, 326 patients (96%) were free of disease. Local failures occurred in 18% of cases; however, after successful salvage surgery this rate was reduced to 11%. Neck failures occurred in 18% of cases, but after successful salvage were reduced to 12%. Distant metastases were rare (1.5%), whereas metachronous cancers were frequent (102 patients). Survival rates were 61% (56% to 66%) at 3 years, 46% (41% to 51%) at 5 years, and 26% (23% to 34%) at 10 years. Deaths due to tongue cancer evolution (20%) equalled those due to metachronous cancers (18.5%) and intercurrent diseases (21%).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358334     DOI: 10.1002/hed.2880120307

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Brachytherapy of stage II mobile tongue carcinoma. Prediction of local control and QOL.

Authors:  Sayako Oota; Hitoshi Shibuya; Ryo-ichi Yoshimura; Hiroshi Watanabe; Masahiko Miura
Journal:  Radiat Oncol       Date:  2006-07-12       Impact factor: 3.481

Review 2.  Is there any place for LDR brachytherapy for head and neck carcinomas in HDR era?

Authors:  Jacek Fijuth
Journal:  J Contemp Brachytherapy       Date:  2009-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.